Pancreatic Cancer Research

ResearcherUniversity of GenoaNo recent work listed

Inga Bauer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0112-0712; OpenAlex author ID A5024750951. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper

Papers 2

  1. The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level. Co-author DOI 10.18632/oncotarget.8437↗
  2. The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. Co-author DOI 10.1074/jbc.m112.405837↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alessio Nencioni · 2 shared papers, 2012–2016 · strength 0.08
  2. Georg Feldmann · 2 shared papers, 2012–2016 · strength 0.08
  3. Natthakan Thongon · 1 shared paper, 2016 · strength 0.05
  4. Alessandro Provenzani · 1 shared paper, 2016 · strength 0.05
  5. Raul Mostoslavsky · 1 shared paper, 2012 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.